AALL1731: A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblast

Cancer Type

Lymphoma, Lymphoid Leukemia

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Anne–Marie Langevin MD

For more information about this study

View Details